Hudson Bay Capital Management
LUMO

Hudson Bay Capital Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Hudson Bay Capital Management’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-10,544
Closed -$483K – 1008
2018
Q1 		$688K Sell
10,544
-3,345
-24% -$237K 0.01% 641
2017
Q4 		$1.01M Buy
+13,889
New +$1.15M 0.02% 393

Other funds holding LUMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hudson Bay Capital Management's LUMO Position: Q2 2018 in Review

Hudson Bay Capital Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2018, closing a stake of 10,544 shares — an estimated $483K sold.

Hudson Bay Capital Management first reported a position in LUMO in Q4 2017 and held it in 2 quarters. The position peaked at $1.01M in Q4 2017. 106 funds tracked by Wall St. Rank hold LUMO as of Q2 2018.

  • Hudson Bay Capital Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • Hudson Bay Capital Management sold 10,544 Lumos Pharma, Inc. Common Stock shares in Q2 2018, an estimated $483K.
  • Hudson Bay Capital Management first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2017 and held it in 2 quarters.
  • Hudson Bay Capital Management's Lumos Pharma, Inc. Common Stock position peaked at $1.01M in Q4 2017.
  • 106 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2018.

Based on Hudson Bay Capital Management's 13F filing for Q2 2018, filed 13 Aug 2018.